![Ryan Martins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Martins
Financieel Directeur/CFO bij
89BIO, INC.
Profiel
Ryan Stephen Martins is currently Chief Financial Officer at 89bio, Inc., a position held since 2019.
Formerly, Mr. Martins was Chief Financial Officer at Revolution Medicines, Inc. in 2018; VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc. from 2015 to 2018; Senior Biotechnology Analyst at Jefferies LLC from 2014 to 2015; Senior Biotechnology Analyst at FM Partners Holdings LLC from 2013 to 2014; Vice President at Barclays Capital, Inc. from 2008 to 2011; Associate at Lehman Brothers, Inc. from 2006 to 2008; Principal at Chiron Corp.
in 2006.
Education includes degrees from Virginia Polytechnic Institute & State University (graduate, 2001), the University of Mumbai (undergraduate and graduate), Haas School of Business (MBA), and St. Xavier's College (undergraduate).
Actieve functies van Ryan Martins
| Bedrijven | Functie | Begin |
|---|---|---|
| 89BIO, INC. | Financieel Directeur/CFO | 01-07-2019 |
Eerdere bekende functies van Ryan Martins
| Bedrijven | Functie | Einde |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Financieel Directeur/CFO | 01-10-2018 |
| ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01-03-2018 |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-07-2015 |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31-01-2014 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Opleiding van Ryan Martins
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Virginia Polytechnic Institute & State University
 Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Xavier's College
 St. Xavier's College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
